Plus Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Plus Therapeutics (PSTV) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Plus Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Plus Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Plus Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $146 | 100 | 1.46 |
| 2024-06-30 | $147 | 100 | 1.47 |
| 2024-03-31 | $181 | 100 | 1.81 |
| 2023-12-31 | $177 | 99 | 1.79 |
| 2023-09-30 | $3 | 2 | 1.50 |